Grove Bank & Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Grove Bank & Trust’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$587	Sell	2 -9	-82%	-$2.55K	﹤0.01%	854
2026 Q1	$3.07K	Sell	11 -17	-61%	-$4.9K	﹤0.01%	757
2025 Q4	$8.48K	Buy	+28	New	+$8.74K	﹤0.01%	665
2025 Q2	–	Sell	-26	Closed	-$6.33K	–	858
2025 Q1	$6.33K	Buy	26 +17	+189%	+$5.11K	﹤0.01%	640
2024 Q4	$2.96K	Hold	9	–	–	﹤0.01%	658
2024 Q3	$3.01K	Buy	+9	New	+$2.86K	﹤0.01%	617

Other funds holding BIO

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return